Concepedia

Yoshitomi Kanemitsu

YK

11

Publications

1K

Citations

11

H-Index

2011

Active since

Affiliations

Tohoku University(Current)

Tohoku Medical Megabank Organization

Keio University

Japan Science and Technology Agency

Tsukuba Medical Center Hospital

Yoshitomi Kanemitsu is an author at Tohoku University specializing in medicine, pharmacology, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2011–2021

11

Publications

11

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease

Kôichi Kikuchi, Daisuke Saigusa, Yoshitomi Kanemitsu et al. · Nature Communications · 2019 · 288 citations · Full text

Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS–based metabolomics approach

Eikan Mishima, Shinji Fukuda, Chikahisa Mukawa et al. · Kidney International · 2017 · 233 citations · Full text

, , +27

Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1–IKKϵ–IRF3 axis activation

Hiroki Tsukamoto, Shino Takeuchi, Kanae Kubota et al. · Journal of Biological Chemistry · 2018 · 199 citations · Full text

Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model

Eikan Mishima, Shinji Fukuda, Yoshitomi Kanemitsu et al. · American Journal of Physiology-Renal Physiology · 2017 · 102 citations · Full text

, , +20

The guanylate cyclase C agonist linaclotide ameliorates the gut–cardio–renal axis in an adenine-induced mouse model of chronic kidney disease

Fumika Nanto-Hara, Yoshitomi Kanemitsu, Shinji Fukuda et al. · Nephrology Dialysis Transplantation · 2019 · 71 citations · Full text

Rows per page

1–5 of 11